Vertex Pharmaceuticals (VRTX) Fails to deliver data

Key failure to deliver metrics for Vertex Pharmaceuticals:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: €17.69 M
• Last 3 months FTD volume: €20.22 M
• Last year FTD volume: €20.22 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Vertex Pharmaceuticals (VRTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Vertex Pharmaceuticals (VRTX) - since 2013

Vertex Pharmaceuticals (VRTX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	€29.33 M	€0.23 B	🇺🇸 USA
AbbVie ABBV	€75.4 M	€0.15 B	🇺🇸 USA
Merck MRK	€14.45 M	€88.44 M	🇺🇸 USA
Bristol-Myers Squibb BMY	€29.95 M	€0.31 B	🇺🇸 USA
Johnson & Johnson JNJ	€70.18 M	€0.32 B	🇺🇸 USA
Enanta Pharmaceuticals ENTA	€0 M	€0.35 M	🇺🇸 USA